Gene · 4547
Papers2,741
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 2,741
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Trovafloxacin drives inflammation-associated drug-induced adverse hepatic reaction by changing macrophage polarization. | Toxicol In Vitro | 2022 | 35537566 | PubTator, text mining | PubMed |
| Molecular Mechanisms of Sphingolipid Transport on Plasma Lipoproteins. | Adv Exp Med Biol | 2022 | 35503174 | PubTator, text mining | PubMed |
| The Relationship of Circulating Proprotein Convertase Subtilisin/Kexin Type 9 With TSH and Lipid Profile in Newly Diagnosed Patients With Subclinical and Overt Hypothyroidism. | Clin Med Insights Endocrinol Diabetes | 2022 | 35494422 | PubTator, text mining | PubMed |
| Hibiscus sabdariffa extract improves hepatic steatosis, partially through IRS-1/Akt and Nrf2 signaling pathways in rats fed a high fat diet. | Sci Rep | 2022 | 35487948 | PubTator, text mining | PubMed |
| Molecular and neurological features of MELAS syndrome in paediatric patients: A case series and review of the literature. | Mol Genet Genomic Med | 2022 | 35474314 | PubTator, text mining | PubMed |
| Is Liver Transplant Curative in Homozygous Familial Hypercholesterolemia? A Review of Nine Global Cases. | Adv Ther | 2022 | 35471728 | PubTator, text mining | PubMed |
| Mitochondrial Ataxias: Molecular Classification and Clinical Heterogeneity. | Neurol Int | 2022 | 35466209 | PubTator, text mining | PubMed |
| Advancements in the Treatment of Homozygous Familial Hypercholesterolemia. | J Atheroscler Thromb | 2022 | 35466160 | PubTator, text mining | PubMed |
| Neuropsychological Features of Children and Adolescents With Mitochondrial Disorders: A Descriptive Case Series. | Front Psychiatry | 2022 | 35463509 | PubTator, text mining | PubMed |
| Whole-exome sequencing reveals damaging gene variants associated with hypoalphalipoproteinemia. | J Lipid Res | 2022 | 35460704 | PubTator, text mining | PubMed |
| MicroRNA-200c coordinates HNF1 homeobox B and apolipoprotein O functions to modulate lipid homeostasis in alcoholic fatty liver disease. | J Biol Chem | 2022 | 35460694 | PubTator, text mining | PubMed |
| Inflammation and atherosclerosis: signaling pathways and therapeutic intervention. | Signal Transduct Target Ther | 2022 | 35459215 | PubTator, text mining | PubMed |
| APOB CRISPR-Cas9 Engineering in Hypobetalipoproteinemia: A Promising Tool for Functional Studies of Novel Variants. | Int J Mol Sci | 2022 | 35457099 | PubTator, text mining | PubMed |
| Novel Pharmaceutical and Nutraceutical-Based Approaches for Cardiovascular Diseases Prevention Targeting Atherogenic Small Dense LDL. | Pharmaceutics | 2022 | 35456658 | PubTator, text mining | PubMed |
| Discovery of 5,7-Dimethoxy-2-(3,4,5-trimethoxyphenoxy)-chromen-4-one with Lipid Lowering Effects in Hepatocytes. | Pharmaceuticals (Basel) | 2022 | 35455445 | PubTator, text mining | PubMed |
| The Interplay of Microtubules with Mitochondria-ER Contact Sites (MERCs) in Glioblastoma. | Biomolecules | 2022 | 35454156 | PubTator, text mining | PubMed |
| Lack of VMP1 impairs hepatic lipoprotein secretion and promotes non-alcoholic steatohepatitis. | J Hepatol | 2022 | 35452693 | PubTator, text mining | PubMed |
| Leukemia inhibitory factor protects against liver steatosis in nonalcoholic fatty liver disease patients and obese mice. | J Biol Chem | 2022 | 35447114 | PubTator, text mining | PubMed |
| Environmental induced transgenerational inheritance impacts systems epigenetics in disease etiology. | Sci Rep | 2022 | 35440735 | PubTator, text mining | PubMed |
| When fat meets the gut-focus on intestinal lipid handling in metabolic health and disease. | EMBO Mol Med | 2022 | 35437952 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4547/papers?page=26